Medical Program: Key Findings from the REVEL Trial

Key Findings from the REVEL Trial

Key Findings from the REVEL Trial
RestartResume

What implications does the REVEL trial have on our approach to treating non-small cell lung cancer patients?

  • Overview

    To find out more about the structure, results, and implications of the REVEL trial, we spoke with Dr. Michael Shafique, Assistant Professor of Thoracic Oncology at the Moffitt Cancer Center in Tampa, Florida.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free